Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


Cancer Survivorship Trials

Social-Media Program for Long-Term Cancer Survivors Post Transplant (2605)
INSPIRE for Survivorship after Transplant: A Multicenter Randomized Controlled Trial of an Internet and Social-media Program for Long-term Hematopoietic Cell Transplantation Survivors
Status Conditions Phase Study ID
Recruiting Transplant Survivor NA 2605
NCT01602211
Summary

Researchers are doing this study to examine ways to improve the health of long-term survivors of bone marrow or blood stem cell transplant. Researchers want to know if a survivorship-focused internet program can improve mood, stress, and preventive health care, and provide useful health resources for transplant survivors. In this study, researchers want to compare a survivorship internet program to the standard treatment of currently available internet sites for transplant survivors to learn which works better for people who have received bone marrow or blood stem cell transplants. Patients in this study will either receive immediate access to the survivorship internet program that includes links to existing resources, or will receive links to existing resources and delayed access to the full internet program. All participants will eventually receive access to the survivorship internet program.


Investigator
Karen Syrjala, PhD
Location    
Seattle Cancer Care Alliance 800-804-8824  
Eligibility Criteria (must meet the following to participate in this study)
  • Received a transplant at a consortium center for a hematologic malignancy
  • Currently 2-10 years after first HCT
Exclusions (conditions that would prevent participation in this study)
  • Does not have internet and email access; note that survivors otherwise eligible, but excluded from full study participation because of this exclusion, will be asked to fill out a mailed copy of the baseline assessment for use in secondary aims analyses; they will be sent an information form and a copy of the tailored 'My Health Action Plan' health care guideline for transplant survivors also provided to randomized participants
  • English insufficient to complete baseline patient-reported outcomes (PRO) assessments
  • Has received treatment for a recurrent or 2nd cancer that required > surgical excision in the past 2 years; (these participants will be ineligible for randomization, but will have intervention site access if they complete baseline PRO assessment)
  • Scores 20 or above on the patient health questionnaire (PHQ)-8 depression measure (indicating severe depression); these participants will be contacted by a study psychologist to evaluate and provide resources to address their needs (2% of enrollees in our previous study); they will be ineligible for randomization, but will have intervention site access if they complete baseline PRO assessment
  • Residing in an institution or other living situation where health care decisions are not made by the participant (e.g., hospitalized, prisoners, living in a rehabilitation facility)
  • Does not complete baseline PRO assessment items required to determine stratification or whether the survivor meets inclusion and exclusion criteria
Last Updated
January 16, 2013
See this trial at ClinicalTrials.gov
Access protocol and consent forms at Fred Hutchinson Cancer Research Center
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:
  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.